Angiotensin I-converting enzyme ACE 2350*G and ACE-240*T-related genotypes and alleles are associated

article OA: closed CC0
View on OpenAlex

Abstract

Endometriosis displays features similar to malignancy, ranging from neovascularization to local invasion and aggressive spread to distant organs. The altered vascular-related genes might be related to the development of endometriosis. This study investi-gates whether angiotensin I-converting enzyme (ACE) *A2350G and A-240T gene polymorphisms could be used as markers of susceptibility in endometriosis. Women were divided into two groups: (1) endometriosis group (n 5 150) and (2) non-endome-triosis group (n 5 159). Genomic DNA was obtained from peripheral leukocytes. ACE A2350G and A-240T gene polymorph-isms were amplified by PCR and detected after restriction enzyme digestion with Bst UI and Xba I. Genotypes and allelic frequencies in both groups were compared. We observed that genotype distribution and allele frequency of ACE 2350 and ACE-240 gene polymorphisms in both groups were significantly different. Proportions of ACE 2350*A homozygote/heterozygo-te/G homozygote in both groups were: (1) 66.7/29.3/4 % and (2) 96.2/3.1/0.7%. Proportions of ACE-240*A homozygote/hetero-zygote/T homozygote in both groups were: (1) 43.3/46/10.7 % and (2) 62.9/35.8/1.3%. We concluded that ACE 2350*G and ACE-240*T-related genotypes and alleles are associated with higher susceptibility to endometriosis. ACE A2350G and A-240T gene polymorphisms might be associated with endometriosis development. Key words: angiotensin I-converting enzyme/ACE/endometriosis/polymorphism/SNP

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-05-10T11:07:14.449418+00:00
License: CC0 · commercial use OK